StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) to acquire V-Wave in deal worth up to $1.7bn
August 20, 2024 8:40 AM
(Updated - August 20, 2024 11:13 AM EDT)
Johnson & Johnson (NYSE: JNJ) announced Tuesday that it has struck ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hot List
Mergers and Acquisitions
Next Articles
Johnson & Johnson gets green light for lung cancer combination treatment
August 20, 2024 7:49 AM
J&J to buy medical device maker V-Wave for up to $1.7 billion
August 20, 2024 7:45 AM
Johnson & Johnson (JNJ) to Acquire V-Wave
August 20, 2024 7:30 AM
Johnson & Johnson to Acquire V-Wave
August 20, 2024 7:30 AM
J&J's chemotherapy-free treatment for lung cancer gets US approval
August 20, 2024 7:17 AM
Johnson & Johnson (JNJ) Announces RYBREVANT plus LAZCLUZE approved in the U.S.
August 20, 2024 7:01 AM
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer
August 20, 2024 7:00 AM
